- Published at
- by manilatimes.net
positive
positive
News for Myriad Genetics, Inc. (MYGN)
- Published at
- by gurufocus.com
positivepositiveMyriad Genetics Names Brian Donnelly as New Chief Commercial Officer
SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. ( MYGN), a leader in molecular diagnostics testing and precision medicine, announced- Published at
- by gurufocus.com
mixedmixed- Published at
- by benzinga.com
mixedmixedExcelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - American Axle & Mfg Hldgs (NYSE:AXL), Alumis (NASDAQ:ALMS)
U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Tuesday. Shares of Excelerate Energy, Inc. EE fell sharply in ...- Published at
- by benzinga.com
mixedmixedWhy PVH Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - bioAffinity Technologies (NASDAQ:BIAF), Cambium Networks (NASDAQ:CMBM)
Shares of PVH Corp. PVH rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter financial results. Calvin Kle...- Published at
- by benzinga.com
mixedmixedWhy PVH Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - bioAffinity Technologies (NASDAQ:BIAF), Cambium Networks (NASDAQ:CMBM)
Shares of PVH Corp. PVH rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter financial results. Calvin Kle...- Published at
- by zacks.com
positivepositiveIs Myriad Genetics Stock Worth Holding in Your Portfolio Now?
Strategic progress and solid potential in oncology testing keep MYGN on investors' radar.- Published at
- by gurufocus.com
neutralneutralMyriad Genetics (MYGN) Stock Jumps on Analyst Upgrade
Shares of Myriad Genetics (MYGN) surged 3.51% today after analysts at Piper Sandler upgraded the stock's rating from Neutral to Buy. This upgrade reflects optim- Published at
- by benzinga.com
mixedmixedThis HubSpot Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Crocs (NASDAQ:CROX), Eaton Corp (NYSE:ETN)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...- Published at
- by zerohedge.com
mixedmixed- Published at
- by gurufocus.com
negativenegativeMyriad Genetics Inc (MYGN) Partners with Gabbi to Enhance Breast Cancer Risk Assessment
On February 27, 2025, Myriad Genetics Inc (MYGN), a leader in molecular diagnostics and precision medicine, announced a strategic collaboration with Gabbi, a te- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
positivepositiveMyriad Genetics Inc (MYGN) Reports Strong Q4 2024 Results and Strategic Developments
Myriad Genetics Inc (MYGN), a leader in genetic testing and precision medicine, announced its financial results for the fourth quarter and full-year ending Dece- Published at
- by gurufocus.com
positivepositiveMyriad Genetics Inc (MYGN) Announces Leadership Transition with New CEO and COO Appointments
Myriad Genetics Inc (MYGN), a prominent player in molecular diagnostics and precision medicine, announced on February 24, 2025, the appointment of Sam Raha as t- Published at
- by gurufocus.com
neutralneutralMyriad Genetics Inc (MYGN) Partners with PATHOMIQ for AI-Driven Prostate Cancer Diagnostics
On February 24, 2025, Myriad Genetics Inc (MYGN), a leader in molecular diagnostic testing and precision medicine, announced a strategic collaboration with PATH- Published at
- by gurufocus.com
positivepositiveMyriad Genetics Inc (MYGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Partnerships Propel Future Prospects
Revenue Growth: 11% increase in 2024 compared to 2023.Adjusted Gross Profit: Approximately $589 million in 2024.Adjusted EBITDA: $40 million in 2024.Adjusted E- Published at
- by gurufocus.com
positivepositiveQ4 2024 Myriad Genetics Inc Earnings Call Transcript
Feb 24, 2025 / 09:30PM GMTOperator Good day, and thank you for standing by. Welcome to the Myriad Genetics fourth quarter 2024 financial earnings conference cal- Published at
- by seekingalpha.com
positivepositiveMyriad Genetics, Inc. (MYGN) Q4 2024 Earnings Call Transcript
Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2024 Results Conference Call February 24, 2025 4:30 PM ETCompany ParticipantsMatt Scalo - Senior Vice President of...- Published at
- by zacks.com
neutralneutralMyriad Genetics (MYGN) Meets Q4 Earnings Estimates
Myriad (MYGN) delivered earnings and revenue surprises of 0% and 0.22%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by gurufocus.com
neutralneutralMyriad Genetics Reports Q4 Revenue of $211 Million, Slightly Missing Estimates; EPS Aligns with Expectations
Quarterly Revenue: $211 million, slightly below the estimated $211.62 million, but up 7% year-over-year, driven by strong demand in Pharmacogenomics and Prenat